Structural insights into redox homeostasis
氧化还原稳态的结构见解
基本信息
- 批准号:7792191
- 负责人:
- 金额:$ 22.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-01 至 2013-03-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAcuteAddressAgingAllosteric RegulationAnabolismApoptosisAreaAtherosclerosisBindingBiochemicalBiological ProcessBuffersC-terminalCell SurvivalCell physiologyChemicalsChronicCoenzymesCommitComplexCysteineDiabetes MellitusDiseaseDisulfidesDrug Metabolic DetoxicationElectron TransportEnzymatic BiochemistryEnzymesEquilibriumEventExhibitsFamilyFlavoproteinsGamma-glutamyl transferaseGlutamate-Cysteine LigaseGlutamatesGlutathioneGlutathione DisulfideGlutathione ReductaseGlycineGoalsHealthHoloenzymesHomeostasisMaintenanceMalignant NeoplasmsMitochondriaMolecularNADPNeurodegenerative DisordersNitrogenNucleotide BiosynthesisOrganismOxidation-ReductionOxidoreductaseOxygenPathway interactionsPost-Translational RegulationProcessProteinsRegulationResearchResearch PersonnelRheumatoid ArthritisSelenocysteineSignal TransductionStructural BiologistStructureSulfhydryl CompoundsSystemThioredoxinTrainingTranslatingage relatedcofactordesigndisulfide bonddithioleffective therapyelectron donorenzyme mechanismglutaredoxininsightnew therapeutic targetoxidative damageprogramsprotein functionthioredoxin reductase
项目摘要
DESCRIPTION (provided by applicant): Efficient intracellular electron transfer is essential to organisms that use oxygen. An exquisite balance between oxidized and reduced enzymes and cofactors, termed redox homeostasis, must be carefully regulated to maintain cellular function. Loss of redox balance underlies molecular changes associated with aging and age related diseases. Consequences of acute or chronic disruption in redox homeostasis include neurodegenerative diseases, cancer, diabetes mellitus, atherosclerosis, and rheumatoid arthritis. To investigate the specific molecular and chemical events that govern redox balance, structural and biochemical studies of enzymes that preserve cellular redox potential will be examined. In particular, the proposed research will consider the enzymatic pathways responsible for the maintenance of reduced thioredoxin and glutathione pools by addressing the following specific aims: (i) Characterize the electron transfer cascade catalyzed by mitochondrial thioredoxin reductase at the molecular level. The goal of this aim is to use structural analysis and biochemical characterizations to examine the mechanistic details of the thioredoxin system as it pertains to mitochondrial redox homeostasis. We will determine the crystal structures of mitochondrial thioredoxin and glutaredoxin alone and in complex with mitochondrial thioredoxin reductase. (ii) investigate the structural and mechanistic features of essential glutathione homeostasis enzymes. The goal of this aim is to gain insight into the regulation of glutathione levels. We will examine the molecular details of allosteric regulation of glutamate cysteine ligase, which catalyzes the committed step of glutathione bisoynthesis. We will also examine the auto-activation mechanism of g-glutamyl transpeptidase, an ectoenzyme required for glutathione salvage, and the effects of self-processing on catalytic activity. Structural characterizations of these key thioredoxin and glutathione systems will provide new insights into mechanisms of cellular redox homeostasis. Understanding the crucial details may translate to new therapeutic targets in the array of difficult health problems caused by oxidative damage.
描述(申请人提供):高效的细胞内电子转移对于使用氧气的生物体至关重要。氧化和还原酶和辅因子之间的微妙平衡,称为氧化还原稳态,必须仔细调节以维持细胞功能。氧化还原平衡的丧失是与衰老和年龄相关疾病相关的分子变化的基础。氧化还原稳态的急性或慢性破坏的后果包括神经退行性疾病、癌症、糖尿病、动脉粥样硬化和类风湿性关节炎。为了研究控制氧化还原平衡的特定分子和化学事件,将检查保持细胞氧化还原电位的酶的结构和生物化学研究。特别是,拟议的研究将考虑负责维持还原硫氧还蛋白和谷胱甘肽池的酶途径,解决以下具体目标:(i)表征线粒体硫氧还蛋白还原酶在分子水平上催化的电子传递级联。这个目标的目的是使用结构分析和生化表征,以检查的硫氧还蛋白系统的机制细节,因为它属于线粒体氧化还原稳态。我们将确定线粒体硫氧还蛋白和谷氧还蛋白单独和与线粒体硫氧还蛋白还原酶复合的晶体结构。(ii)研究必需谷胱甘肽稳态酶的结构和机制特征。这个目标的目的是深入了解谷胱甘肽水平的调节。我们将研究谷氨酸半胱氨酸连接酶的变构调节的分子细节,该酶催化谷胱甘肽双合成的关键步骤。我们还将研究谷胱甘肽补救所需的胞外酶g-谷氨酰转肽酶的自激活机制,以及自处理对催化活性的影响。这些关键的硫氧还蛋白和谷胱甘肽系统的结构特征将提供新的见解细胞氧化还原稳态的机制。了解关键的细节可能会转化为新的治疗目标,在一系列困难的健康问题所造成的氧化损伤。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH J BARYCKI其他文献
JOSEPH J BARYCKI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH J BARYCKI', 18)}}的其他基金
Defining aberrant steroid elimination in castration resistant prostate cancer
去势抵抗性前列腺癌中异常类固醇消除的定义
- 批准号:
8881763 - 财政年份:2015
- 资助金额:
$ 22.26万 - 项目类别:
MECHANISTIC STUDIES OF GLUTATHIONE METABOLIC ENZYMES
谷胱甘肽代谢酶的机理研究
- 批准号:
7956827 - 财政年份:2009
- 资助金额:
$ 22.26万 - 项目类别:
COBRE: U NEL: P5: MACROMOLECULAR CRYSTALLOGRAPHY: ENZYM/CRYSTALLOG GSH ENZYMES
COBRE:U NEL:P5:大分子晶体学:酶/晶体 GSH 酶
- 批准号:
7381830 - 财政年份:2006
- 资助金额:
$ 22.26万 - 项目类别:
COBRE: U NEL: P5: MACROMOLECULAR CRYSTALLOGRAPHY: ENZYM/CRYSTALLOG GSH ENZYMES
COBRE:U NEL:P5:大分子晶体学:酶/晶体 GSH 酶
- 批准号:
7171060 - 财政年份:2005
- 资助金额:
$ 22.26万 - 项目类别:
MACROMOLECULAR CRYSTALLOGRAPHY: ENZYM/CRYSTALLOG GSH ENZ
高分子晶体学:酶/晶体 GSH ENZ
- 批准号:
6981747 - 财政年份:2004
- 资助金额:
$ 22.26万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 22.26万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 22.26万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 22.26万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 22.26万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 22.26万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 22.26万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 22.26万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 22.26万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 22.26万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别:
Standard Grant














{{item.name}}会员




